10,11 The availability of an additional pharmacologic test would be most useful ... or even presumptive evidence, of a pheochromocytoma. In the case reported herein, adrenergic blockade was ...
The panel of experts at the ISP felt strongly that localization of pheochromocytoma or paraganglioma ... biochemical test results should be strongly positive. If the pretest probability of a ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
Low-osmolar, contrast-enhanced CT can be safely used in patients with pheochromocytoma. “This tool will enhance physicians' abilities to diagnose and treat patients with pheochromocytoma ...
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
The role of chromogranin A in the assessment of surgical cure of pheochromocytoma was also investigated. The authors observed 21 consecutive patients who had pheochromocytomas at initial ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback